Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant allergens for immunotherapy.

Martin D Chapman1, Alisa M Smith, Lisa D Vailes

  • 1Asthma and Allergic Diseases Center, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.

Allergy and Asthma Proceedings
|March 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baking results in impaired detection of clinically relevant food allergens.

Frontiers in allergy·2026
Same author

Pragmatic Strategies for Reducing Variability and Risk in Food Oral Immunotherapy.

Clinical reviews in allergy & immunology·2026
Same author

Correlates of cockroach nasal challenge responsiveness among sensitized urban children with asthma.

The journal of allergy and clinical immunology. Global·2026
Same author

Reclassification of GST Allergens Based on Their Cross-Reactivity in Two Divergent Cockroach Species.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

A novel ambient air sampler for detection of allergens and endotoxin.

The journal of allergy and clinical immunology. Global·2026
Same author

New Allergens Approved by the WHO/IUIS Allergen Nomenclature Sub-Committee in 2021-2024 and Their Significance for Future Diagnostics, Regulation, and Research. An EAACI Task Force Report.

Allergy·2025
Same journal

Key factors in the diagnosis of sesame allergy in children.

Allergy and asthma proceedings·2026
Same journal

Immunoglobulin E-mediated pumpkin seed allergy in children: Case series and narrative review with a structured literature search.

Allergy and asthma proceedings·2026
Same journal

Predictors of delayed treatment-free remission with omalizumab in chronic spontaneous urticaria.

Allergy and asthma proceedings·2026
Same journal

The digital front door: A national analysis of U.S. allergy and immunology fellowship program web sites.

Allergy and asthma proceedings·2026
Same journal

The impact of dietary patterns on the risk of asthma in children.

Allergy and asthma proceedings·2026
Same journal

The alpha-gal syndrome: Understanding the role of tick bites, and the delays in severe anaphylaxis.

Allergy and asthma proceedings·2026
See all related articles

Genetically engineered recombinant allergens offer solutions for allergy diagnosis and treatment. These advanced allergens demonstrate comparable efficacy to natural ones and pave the way for novel immunotherapy strategies.

Area of Science:

  • Biotechnology
  • Immunology
  • Allergology

Background:

  • Natural allergens present challenges in diagnosis and treatment.
  • Recombinant allergens offer a viable alternative, overcoming limitations of natural sources.

Purpose of the Study:

  • To review the development and application of recombinant allergens.
  • To highlight their potential in advancing allergy diagnosis and immunotherapy.

Main Methods:

  • Cloning, sequencing, and expression of major allergens from various sources (mites, pollens, dander, insects, foods).
  • Utilizing high-level expression systems in bacteria, yeast, or insect cells.
  • Characterization of recombinant allergens for IgE binding and diagnostic reactivity.

Main Results:

Related Experiment Videos

  • Successful cloning and expression of key allergens over the past decade.
  • Recombinant allergens exhibit comparable IgE binding to natural allergens.
  • Demonstrated excellent reactivity in skin testing and in vitro diagnostic assays.

Conclusions:

  • Recombinant allergens provide a reliable alternative to natural allergens for diagnosis.
  • They are crucial for developing innovative allergen immunotherapy strategies.
  • Future applications include peptide-based vaccines, hypoallergens, and prophylactic vaccines.